.BETA.-D-GLUCOPYRANURONIC ACID, 1-((2S,4S)-2-((3,3-DIFLUORO-1-PYRROLIDINYL)CARBONYL)-4-(4-(2-PYRIMIDINYL)-1-PIPERAZINYL)-1-PYRROLIDINECARBOXYLATE)
UNII 7B38O293HC

Substance Identification & Data

This profile provides standardized clinical and technical data for .beta.-d-glucopyranuronic Acid, 1-((2s,4s)-2-((3,3-difluoro-1-pyrrolidinyl)carbonyl)-4-(4-(2-pyrimidinyl)-1-piperazinyl)-1-pyrrolidinecarboxylate), uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7B38O293HC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1424328-23-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7B38O293HC

CAS Registry Number

1424328-23-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

.BETA.-D-GLUCOPYRANURONIC ACID, 1-((2S,4S)-2-((3,3-DIFLUORO-1-PYRROLIDINYL)CARBONYL)-4-(4-(2-PYRIMIDINYL)-1-PIPERAZINYL)-1-PYRROLIDINECARBOXYLATE)

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C24H32F2N6O9

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WJFYIIZQOWPJRA-LPRKUSKOSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

118753123

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1CC(CN1C([C@@H]2C[C@@H](CN2C(O[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)C(O)=O)=O)N4CCN(CC4)c5ncccn5)=O)(F)F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for .beta.-d-glucopyranuronic Acid, 1-((2s,4s)-2-((3,3-difluoro-1-pyrrolidinyl)carbonyl)-4-(4-(2-pyrimidinyl)-1-piperazinyl)-1-pyrrolidinecarboxylate). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.